オーソバイオロジクスの世界市場予測

Inkwood Researchが発行した調査報告書(INKW709115)
◆英語タイトル:Global Orthobiologics Market Forecast 2017-2025
◆商品コード:INKW709115
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2017年7月19日
◆ページ数:132
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

Inkwood Research社が出版した本調査レポートでは、オーソバイオロジクスの世界市場について調査・分析し、オーソバイオロジクスの世界市場動向、市場予測、セグメント別分析、主要地域別分析(アメリカ市場、ヨーロッパ市場、アジア市場)、世界市場規模、関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

KEY FINDINGSThe orthobiologics global market is anticipated to grow from $ 6596 million in 2016 to $ 12019 million by 2025. The market is expected to grow at a CACR of 6.97% between 2017-2027. The base year considered for the market study is 2016. The forecast period is 2017-2025. Evolvement in orthobiologics has led to the development of tissue regeneration products and bone grafts that minimize hospital visits, stays and bone healing process.
MARKET INSIGHTS
The global orthobiologics market is segmented on the basis of product type, application, end-user, and geography. The global orthobiologics market by product type is segmented into the demineralized bone matrix (DBM), allograft, bone morphogenetic protein, viscosupplementation, synthetic bone graft substitutes, stem cell therapy and others. The application segment is further bifurcated into spinal fusion, trauma repair, and reconstructive surgery and others. The end-user is segmented into hospitals and clinics. The orthobiologics market by geography is classified into North America, Europe, Asia-Pacific and rest of the world. The rise in the demand for spinal fusion surgeries, development in Strategic Partnerships, and growth in Orthobiologics Material are the major drivers for the global Orthopedics market. Healthcare reforms (such as Stark self-referral law and fraud & abuse law) are estimated to have affected the Orthobiologics surgeons. Bone Regeneration Technology, Larger Spend on Healthcare is the major opportunities in the Orthobiologics Market.
REGIONAL INSIGHTS
The Orthobiologics market in North America is expected to hold the colossal share by 2024. The increase in research and a rising demand for the products, increasing research investments, aging population growth and an increased number of road accidents are major drivers of the region. Asia-Pacific is estimated with the highest CAGR of 7.09% due to the increased demand for biological implants over mechanical implants, coupled with the growing awareness levels about the benefits of Orthobiologics. Europe has generated revenue of $1705 million in 2016 and is expected to generate revenue of $3077 million by 2024. The rise in the aging population, increased incidences of osteoarthritis and osteoporosis, technological advancements in the European countries are driving the market to grow at a faster pace.
COMPETITIVE INSIGHTS
Major players for the Orthobiologics market are Bioventus, DePuy Inc. (Acquired by Johnson and Johnson), Exatech Inc., Globus Medical Inc., Integra Life sciences Holding Corporation, Johnson& Johnson, Medtronic Inc., Nuvasive Inc., RTI Surgical, Sanofi, Stryker Corporation, Zimmer Biomet Inc., and Mölnlycke Health Care AB. DePuy Inc.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
3.1.1. ASIA-PACIFIC TO GROW AT A MAGNIFICENT RATE
3.1.2. NORTH AMERICA TO BE THE GLOBAL LEADER
3.1.3. HOSPITALS SEGMENT IS THE LARGEST REVENUE GENERATION
3.1.4. SPINAL FUSION IS THE MOST SIGNIFICANT MARKET BY APPLICATION
3.1.5. VISCOSUPPLEMENTATION GENERATED THE HIGHEST REVENUE IN TERMS OF PRODUCTS
4. MARKET OVERVIEW
4.1. MARKET DRIVERS
4.1.1. DEMAND FOR SPINAL FUSION SURGERIES
4.1.2. GROWTH IN STRATEGIC PARTNERSHIPS
4.1.3. INCREASE IN ORTHOBIOLOGICS MATERIAL
4.2. RESTRAINTS
4.2.1. STRINGENT GOVERNMENT POLICIES
4.2.2. POST-SURGERY COMPLICATIONS
4.3. OPPORTUNITIES
4.3.1. BONE REGENERATION TECHNOLOGY
4.3.2. LARGER SPEND ON HEALTHCARE
4.4. CHALLENGES
4.4.1. HIGH COST OF SPINAL FUSION SURGERY
4.4.2. PRODUCT SIDE EFFECTS AND FDA SCRUTINY
4.4.3. POOR PERFORMANCE OF BONE GRAFT SUBSTITUTE
5. SEGMENTATION
5.1. BY PRODUCTS
5.1.1. DEMINERALIZED BONE MATRIX (DBM)
5.1.2. ALLOGRAFT
5.1.3. BONE MORPHOGENETIC PROTEIN (BMP)
5.1.4. VISCOSUPPLEMENTATION
5.1.5. SYNTHETIC BONE GRAFT SUBSTITUTES
5.1.6. STEM CELL THERAPY
5.1.7. OTHERS PRODUCTS MARKET
5.2. BY APPLICATION
5.2.1. SPINAL FUSION
5.2.2. TRAUMA REPAIR
5.2.3. RECONSTRUCTIVE SURGERY
5.2.4. TENDON & LIGAMENT REPAIR MARKET
5.2.5. OTHERS APPLICATION MARKET
5.3. BY END-USER
5.3.1. HOSPITALS MARKET
5.3.2. CLINICS MARKET
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. VALUE CHAIN ANALYSIS
6.5. VENDOR LANDSCAPE
7. REGIONAL ANALYSIS
7.1. NORTH AMERICA ORTHOBIOLOGICS MARKET
7.1.1. UNITED STATES ORTHOBIOLOGICS MARKET
7.1.2. CANADA ORTHOBIOLOGICS MARKET
7.2. EUROPE ORTHOBIOLOGICS MARKET
7.2.1. UNITED KINGDOM ORTHOBIOLOGICS MARKET
7.2.2. FRANCE ORTHOBIOLOGICS MARKET
7.2.3. GERMANY ORTHOBIOLOGICS MARKET
7.2.4. SPAIN ORTHOBIOLOGICS MARKET
7.2.5. ITALY ORTHOBIOLOGICS MARKET
7.2.6. ROE ORTHOBIOLOGICS MARKET
7.3. ASIA-PACIFIC ORTHOBIOLOGICS MARKET
7.3.1. INDIA ORTHOBIOLOGICS MARKET
7.3.2. CHINA ORTHOBIOLOGICS MARKET
7.3.3. JAPAN ORTHOBIOLOGICS MARKET
7.3.4. AUSTRALIA ORTHOBIOLOGICS MARKET
7.3.5. ROAPAC ORTHOBIOLOGICS MARKET
7.4. REST OF THE WORLD ORTHOBIOLOGICS MARKET
7.4.1. LATIN AMERICA ORTHOBIOLOGICS MARKET
7.4.2. MENA ORTHOBIOLOGICS MARKET
7.4.3. AFRICA ORTHOBIOLOGICS MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. MERGERS & ACQUISITIONS
9. COMPANY PROFILE
9.1. BIOVENTUS
9.1.1. OVERVIEW
9.1.2. PRODUCTS PORTFOLIO
9.1.3. STRATEGIC INITIATIVES
9.1.4. SCOT ANALYSIS
9.2. DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. EXATECH INC
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. SCOT
9.3.4. STRATEGIC ANALYSIS
9.4. GLOBUS MEDICAL INC
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES
9.4.4. SCOT
9.4.5. STRATEGIC ANALYSIS
9.5. INTEGRA LIFESCIENCES HOLDING CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. JOHNSON& JOHNSON
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES
9.6.4. SWOT ANALYSIS
9.7. MEDTRONIC INC
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT
9.8. NUVASIVE INC
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT ANALYSIS
9.8.5. STRATEGIC ANALYSIS
9.9. RTI SURGICAL
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.10. SANOFI
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT ANALYSIS
9.11. STRYKER CORPORATION
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. ZIMMER BIOMET INC
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES
9.12.4. STRATEGIC ANALYSIS
9.13. MÖLNLYCKE HEALTH CARE AB
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. STRATEGIC INITIATIVES
9.13.4. SCOT ANALYSIS

TABLE LIST
TABLE # 1 OLDER POPULATION BY AGE GROUP: 1900 TO 2050
TABLE # 2 FINANCING FOR ORTHOBIOLOGICS ADVANCEMENT
TABLE # 3 POST-SURGERY COMPLICATION
TABLE # 4 GLOBAL ORTHOBIOLOGICS MARKET BY PRODUCTS 2017-2025 ($ MILLIONS)
TABLE # 5 DEMINERALIZED BONE MATRIX ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE # 6 ALLOGRAFT ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE # 7 BONE MORPHOGENETIC PROTEIN(BMP) ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE # 8 VISCOSUPPLEMENTATION MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE # 9 SYNTHETIC BONE GRAFT MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE # 10 STEM CELL THERAPY MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE # 11 OTHER PRODUCTS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE # 12 GLOBAL ORTHOBIOLOGICS MARKET BY APPLICATION 2017-2025 ($ MILLIONS)
TABLE # 13 SPINAL FUSION MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE # 14 TRAUMA REPAIR MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE # 15 RECONSTRUCTIVE SURGERY MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE # 16 TENDON & LIGAMENT ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE # 17 OTHER APPLICATIONS ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE # 18 GLOBAL ORTHOBIOLOGICS MARKET BY END-USER , 2017-2025 ($ MILLION)
TABLE # 19 HOSPITAL ORTHOBIOLOGICS MARKET, BY REGION 2017-2025 ($ MILLIONS)
TABLE # 20 ORTHOBIOLOGICS CLINICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE # 21 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
TABLE # 22 EUROPE ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
TABLE # 23 EUROPE POPULATION AGE STRUCTURE BY AGE GROUP 2015
TABLE # 24 ASIA-PACIFIC ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
TABLE # 25 INJURIES CAUSED IN AUSTRALIA BY SPORTS IN 2015
TABLE # 26 REST OF THE WORLD ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)

FIGURES LIST
FIGURE # 1 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE # 2 DEMINERALIZED BONE MATRIX ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 3 ALLOGRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 4 BONE MORPHOGENIC PROTEIN(BMP) ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 5 VISCOSUPPLEMENTATION ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 6 SYNTHETIC BONE GRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 7 STEM CELL THERAPY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 8 GLOBAL OTHER PRODUCTS MARKET 2017-2025 ($ MILLION)
FIGURE # 9 SPINAL FUSION ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 10 TRAUMA REPAIR ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 11 RECONSTRUCTIVE SURGERY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 12 TENDON & LIGAMENT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 13 OTHER APPLICATIONS ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 14 COST OF KNEE REPLACEMENT IN DEVELOPING COUNTRIES IN 2017
FIGURE # 15 ORTHOBIOLOGICS HOSPITAL MARKET 2017-2025 ($ MILLIONS)
FIGURE # 16 ORTHOBIOLOGICS CLINICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 17 NORTH AMERICA POPULATION AGES 65 AND ABOVE (% OF TOTAL) BY COUNTRIES 2016
FIGURE # 18 NORTH AMERICA ORTHOBIOLOGICS MARKET BY COUNTRY 2016 & 2025(% SHARE)
FIGURE # 19 UNITED STATES (U.S.) ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 20 HEALTHCARE EXPENDITURE IN THE U.S. 2014 & 2025 (% OF GDP)
FIGURE # 21 CANADA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 22 EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2016 & 2025
FIGURE # 23 UNITED KINGDOM ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 24 FRANCE ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 25 AGE STRUCTURE OF GERMANY 2015
FIGURE # 26 GERMANY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 27 AGING POPULATION IN SPAIN 2005 AND 2015 (%)
FIGURE # 28 SPAIN ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 29 ITALY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 30 ROE ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 31 ASIA-PACIFIC ORTHOBIOLOGICS MARKET BY COUNTRY 2016 & 2025
FIGURE # 32 POPULATION AGES 65 AND ABOVE IN TOP 3 COUNTRIES IN ASIA-PACIFIC (% OF TOTAL)
FIGURE # 33 INDIA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 34 CHINA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 35 JAPAN ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 36 AUSTRALIA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 37 ROAPAC ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 38 REST OF THE WORLD ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
FIGURE # 39 LATIN AMERICA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 40 MENA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 41 AFRICA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE # 42 MARKET SHARE OF ORTHOBIOLOGICS COMPANIES 2016 (%)



【レポートのキーワード】

オーソバイオロジクス

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ オーソバイオロジクスの世界市場予測(Global Orthobiologics Market Forecast 2017-2025)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆